A detailed history of Utah Retirement Systems transactions in Eli Lilly & CO stock. As of the latest transaction made, Utah Retirement Systems holds 146,929 shares of LLY stock, worth $133 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
146,929
Previous 146,843 0.06%
Holding current value
$133 Million
Previous $85.6 Million 33.54%
% of portfolio
1.35%
Previous 1.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $50,929 - $68,136
86 Added 0.06%
146,929 $114 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $453,238 - $534,309
863 Added 0.59%
146,843 $85.6 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $305,159 - $420,708
702 Added 0.48%
145,980 $78.4 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $1.69 Million - $2.27 Million
-4,830 Reduced 3.22%
145,278 $68.1 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $155,315 - $182,410
500 Added 0.33%
150,108 $51.6 Million
Q4 2022

Feb 15, 2023

SELL
$321.55 - $374.67 $482,325 - $562,005
-1,500 Reduced 0.99%
149,608 $54.7 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $226,807 - $258,470
765 Added 0.51%
151,108 $48.9 Million
Q2 2022

Aug 16, 2022

SELL
$278.73 - $327.27 $250,857 - $294,543
-900 Reduced 0.6%
150,343 $48.7 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $586,725 - $729,150
-2,500 Reduced 1.63%
151,243 $43.3 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $67,455 - $83,712
300 Added 0.2%
153,743 $42.5 Million
Q3 2021

Nov 16, 2021

SELL
$221.6 - $272.71 $1.79 Million - $2.21 Million
-8,100 Reduced 5.01%
153,443 $35.5 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $54,165 - $70,062
-300 Reduced 0.19%
161,543 $37.1 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $1.17 Million - $1.51 Million
-7,100 Reduced 4.2%
161,843 $30.2 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $952,358 - $1.26 Million
7,300 Added 4.52%
168,943 $28.5 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $160,842 - $186,043
1,100 Added 0.69%
161,643 $23.9 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $245,555 - $295,524
-1,800 Reduced 1.11%
160,543 $26.4 Million
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $128,304 - $158,916
-1,200 Reduced 0.73%
162,343 $21.3 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $32,037 - $34,848
-300 Reduced 0.18%
163,543 $18.3 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $321,844 - $375,674
-2,905 Reduced 1.74%
163,843 $18.2 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $1.17 Million - $1.37 Million
-10,488 Reduced 5.92%
166,748 $21.6 Million
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $21,180 - $23,728
-200 Reduced 0.11%
177,236 $20.5 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $85,860 - $107,310
-1,000 Reduced 0.56%
177,436 $19 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $272,520 - $312,768
-3,600 Reduced 1.98%
178,436 $15.2 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $22,262 - $26,280
300 Added 0.17%
182,036 $14.1 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $196,656 - $210,936
2,400 Added 1.34%
181,736 $15.4 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $13.8 Million - $15.3 Million
179,336
179,336 $15.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.